Admission Date:  [**2170-5-15**]              Discharge Date:   [**2170-5-20**]  Date of Birth:  [**2103-12-21**]             Sex:   F  Service: MEDICINE  Allergies: Tetracycline  Attending:[**First Name3 (LF) 3233**] Chief Complaint: New leukemia   Major Surgical or Invasive Procedure: Bone marrow biopsy - [**2170-5-16**]  History of Present Illness: This is a 66 year old woman with minimal past medical history who is presenting to the ED for a WBC count of 600 on outpatient labs.
Labs drawn the week prior to admission revealed a WBC of 600 and sent her for an outpatient hematology consult who upon seeing her WBC count sent her to the ED (didn't actually see her yet).
On arrival to the ED initial VS were 98.4 87 157/69 18 99/ra.
Noncon head CT was negative.
Family History: no known leukemia, lymphoma or cancer; father with CVA, [**1-22**] sister with DM; does not know maternal history; 2 healthy sons and one healthy gransdson  Physical Exam: Admission Physical Exam: VS: 144/80 85 RR 18 95%/ra General: well, NAD HEENT: MMM, PERRLA, EOMI, no jaundice, sclera normal Neck: supple Heart: RRR no R/G/M Lungs: clear Abdomen: soft, nontender, +bs, splenomegaly extending down to umbilicus Extremities: no edema, 2+ distal pulses Neuro: CN2-12 intact, strength and sensation intact across upper and lower extremities  Discharge Physical Exam: No significant change  Pertinent Results: Admission Labs [**2170-5-15**] 08:40PM: WBC-385.9* RBC-3.47* Hgb-9.0* Hct-27.0* MCV-84 MCH-25.7* MCHC-30.7* RDW-16.1* Plt Ct-125* Neuts-2* Bands-0 Lymphs-87* Monos-1* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 Blasts-0 Other-10* PT-12.3 PTT-30.7 INR(PT)-1.1 Glucose-162* UreaN-17 Creat-0.7 Na-140 K-3.9 Cl-104 HCO3-27 AnGap-13 ALT-16 AST-45* LD(LDH)-503* AlkPhos-175* TotBili-0.4 Albumin-4.7 Calcium-9.0 Phos-4.0 Mg-2.3 UricAcd-6.7* Iron-52 calTIBC-391 Ferritn-88 TRF-301 IgG-934 IgA-49* IgM-83  CT head without contrast [**2170-5-15**]:  No evidence of acute intracranial process.
CXR AP [**2170-5-15**]:  Minimal linear opacity in the left lower lung is likely atelectasis.
CXR PA/Lateral [**2170-5-16**]:  The heart size is stable.
The study and the report were reviewed by the staff radiologist.
CT CHEST W/O CONTRAST; CT ABD & PELVIS W/O CONTRAST 1.
Axillary, mesenteric, retroperitoneal, and pelvic lymphadenopathy.
CT NECK W/O CONTRAST (EG: PAROTIDS) [**2170-5-17**] 4:17 PM Diffuse cervical lymphadenopathy involving all stations and bilateral axillary lymphadenopathy is consistent with lymphoma.
DISCHARGE LABS: [**2170-5-20**] 12:00AM BLOOD WBC-378* RBC-2.91* Hgb-7.3* Hct-25.5* MCV-88 MCH-25.1* MCHC-28.6* RDW-16.8* Plt Ct-97* [**2170-5-20**] 12:00AM BLOOD Neuts-10* Bands-0 Lymphs-90* Monos-0* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2170-5-20**] 12:00AM BLOOD PT-12.0 PTT-27.0 INR(PT)-1.1 [**2170-5-20**] 12:00AM BLOOD Fibrino-171* [**2170-5-20**] 12:00AM BLOOD Glucose-277* UreaN-17 Creat-0.7 Na-141 K-4.3 Cl-106 HCO3-27 AnGap-12 [**2170-5-20**] 12:00AM BLOOD ALT-15 AST-18 LD(LDH)-266* AlkPhos-146* TotBili-0.5 [**2170-5-20**] 12:00AM BLOOD Calcium-8.2* Phos-4.1 Mg-2.4 UricAcd-3.7 [**2170-5-17**] 05:10PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE [**2170-5-17**] 05:10PM BLOOD HIV Ab-NEGATIVE [**2170-5-17**] 05:10PM BLOOD HCV Ab-NEGATIVE  Brief Hospital Course: PRINCIPLE REASON FOR ADMISSION This is a 66 year old woman with newly diagnosed CLL; admission complicated by leukostasis with vision changes.
ACTIVE PROBLEMS # Leukemia with Leukostasis: The patient was sent to the emergency department for vision changes associated with a WBC of 600k.
She underwent bone marrow biopsy that showed CLL (CD5+,CD19+,CD20+DIM,CD10-,CD38+).
Tumor lysis labs remained stable.
HCT remained between 24 and 30 during admission, with overall slight down trend.
She should continue to have frequent monitoring of blood counts as an outpatient.
She was not discharged on diabetic medication, and this should be followed up as an outpatient.
TRANSITIONAL ISSUES - Monitor blood sugar and consider initation of blood sugar lowering agents - Continue to monitor blood counts as outpatient - Complete treatment course of rituxan/bendamustine as per outpatient recommendations  Medications on Admission: HCTZ 12.5mg enalapril 5mg or 10mg (she is unsure) calcium  Discharge Medications: 1. hydrochlorothiazide 12.5 mg Tablet Sig: One (1) Tablet PO once a day.
You will need to see your hematologist Dr [**Last Name (STitle) 110449**] [**Name (STitle) **] on Tuesday [**5-22**], we could not schedule an appointment today.
